Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02454842
Title Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC
Acronym TH-4000
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Threshold Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS


No variant requirements are available.